Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Nature Microbiology|September 11, 2019
Epstein-Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus productionZhe Li, Ming-Han Tsai, Anatoliy Shumilov, et al.Cell Cycle (Georgetown, Tex.)|October 19, 2016
Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenationAnne-Sophie Kratz, Kai T Richter, Yvonne T Schlosser, et al.Plos Pathogens|December 24, 2015
The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B CellsXiaochen Lin, Ming-Han Tsai, Anatoliy Shumilov, et al.Plos Pathogens|December 7, 2018
Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in miceDwain G van Zyl, Ming-Han Tsai, Anatoliy Shumilov, et al.Proceedings of the National Academy of Sciences of the United States of America|October 23, 2021
The Epstein-Barr virus noncoding RNA EBER2 transactivates the UCHL1 deubiquitinase to accelerate cell growthZhe Li, Francesco Baccianti, Susanne Delecluse, et al.Oncotarget|January 5, 2017
The biological properties of different Epstein-Barr virus strains explain their association with various types of cancersMing-Han Tsai, Xiaochen Lin, Anatoliy Shumilov, et al.Plos Pathogens|August 29, 2014
Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized miceOlga Antsiferova, Anne Müller, Patrick C Rämer, et al.Journal of Virology|December 14, 2018
Epstein-Barr Virus Induces Expression of the LPAM-1 Integrin in B Cells In Vitro and In VivoSusanne Delecluse, Ming-Han Tsai, Anatoliy Shumilov, et al.Nature Communications|February 11, 2017
Epstein-Barr virus particles induce centrosome amplification and chromosomal instabilityAnatoliy Shumilov, Ming-Han Tsai, Yvonne T Schlosser, et al.Scientific Reports|May 27, 2024
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancerAnsh Kapil, Andreas Spitzmüller, Nicolas Brieu, et al.Pageof 2